Chronopharmacodynamics and mechanisms of antitumor effect induced by erlotinib in xenograft-bearing nude mice

Biochemical and Biophysical Research Communications
Pingping LinMingchun Li

Abstract

Receptor tyrosine kinases, mediators of a variety of critical cellular functions, contribute to tumor progression and metastasis. The epidermal growth factor receptor (EGFR), a member of the receptor tyrosine kinase family, is ubiquitously expressed on the surface of mammalian cells. Erlotinib hydrochloride (Tarceva) can inhibit the intracellular phosphorylation of tyrosine kinases. To investigate the influence of dosing time on the ability of erlotinib to inhibit tumor growth and the underlying molecular mechanisms via the PI3K/AKT and ERK/MAPK pathway, we established nude mice HCC827 tumor xenografts models. The tumor-bearing mice were housed 3-4 per cage under standardized light/dark cycle conditions (lights on at 07:00 h, off at 19:00 h) with food and water ad libitum. The mice were randomly divided into erlotinib treated groups and control groups, gavaged with erlotinib and vehicle respectively at 6 different time points for 21 days. To draw tumor growth curves, the tumor volume was measured every three days. After the mice were sacrificed, the tumor masses of each group were removed and weighed. The relative protein expression levels of p-EGFR, p-AKT and p-MAPK were assayed at 4 h after erlotinib or vehicle gavage by West...Continue Reading

References

Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Aug 12, 2003·Cancer·Bruno VincenziGiuseppe Tonini
Mar 5, 2004·Expert Opinion on Therapeutic Targets·Jeffrey Sprouse
May 5, 2004·Seminars in Oncology·Wade Smith, Fadlo R Khuri
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas FriessMax Hasmann
Mar 25, 2006·International Journal of Cancer. Journal International Du Cancer·Niels ReinmuthMichael Thomas
Apr 6, 2006·Cancer Causes & Control : CCC·Francis Lévi
Nov 22, 2007·Cancer Chemotherapy and Pharmacology·Laura K ZerbeAlvin M Malkinson
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alba A BrandesRoger Stupp
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L CrinòUNKNOWN ESMO Guidelines Working Group
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Mar 14, 2013·Bioorganic & Medicinal Chemistry Letters·Kristine Griffett, Thomas P Burris
Sep 24, 2013·Clinical Therapeutics·John R Goffin, Kevin Zbuk
Feb 4, 2014·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Haruhisa KitanoStephen M Hewitt

❮ Previous
Next ❯

Citations

Apr 14, 2016·Trends in Molecular Medicine·Robert DallmannFrancis Lévi
Oct 19, 2017·International Journal of Molecular Sciences·Narin OzturkAlper Okyar
Mar 3, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Danyi LuBaojian Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Brain Lower Grade Glioma

Low grade gliomas in the brain form from oligodendrocytes and astrocytes and are the slowest-growing glioma in adults. Discover the latest research on these brain tumors here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis